{"id":53763,"date":"2025-05-09T08:00:00","date_gmt":"2025-05-09T06:00:00","guid":{"rendered":"https:\/\/www.stille.se\/us\/mfn_news\/stille-ab-appoints-ulrik-berthelsen-as-chief-executive-officer\/"},"modified":"2025-05-09T08:00:00","modified_gmt":"2025-05-09T06:00:00","slug":"stille-ab-appoints-ulrik-berthelsen-as-chief-executive-officer","status":"publish","type":"mfn_news","link":"https:\/\/www.stille.se\/us\/news\/stille-ab-appoints-ulrik-berthelsen-as-chief-executive-officer\/","title":{"rendered":"Stille AB appoints Ulrik Berthelsen as Chief Executive Officer"},"content":{"rendered":"
\n

Torsh\u00e4lla, Sweden \u2013 9 May 2025 \u2013 The Board of Directors of Stille AB (\u201cStille\u201d), a leading provider of premium surgical instruments and advanced surgical tables for high-precision procedures, is pleased to announce the appointment of Ulrik Berthelsen as its new Chief Executive Officer, effective 12 May 2025.<\/strong><\/p>\n<\/div>\n

\n

With a distinguished background in the medical technology sector and a proven track record of strategic leadership and of driving growth organically as well as through M&A in both US and European markets, Mr. Berthelsen brings a wealth of experience to Stille. He succeeds Torbj\u00f6rn Sk\u00f6ld, who has been the Chief Executive Officer since 20 Mar 2023.<\/p>\n

Over the past 20 years, Ulrik Berthelsen has held senior international positions, primarily at Coloplast and Atos Medical, where he has led transformative initiatives delivering strong growth and innovation. His appointment marks an exciting new chapter for Stille, as the company continues to expand its global presence and reinforce its commitment to surgical precision and patient care.<\/p>\n

"We are thrilled to welcome Ulrik to Stille,"<\/em> said J\u00f3n Sigurdsson, recently appointed Chairman of the Board of Directors and former long-time CEO of \u00d6ssur\/Embla Medical. "His deep industry knowledge, visionary leadership, and customer-focused approach will be instrumental in driving the next phase of our growth and innovation."<\/em><\/p>\n

Mr. Berthelsen commented: \u201cI am honored to join Stille, a company with a remarkable heritage and strong reputation for quality and innovation. I look forward to working with the team at Stille to build on this foundation and accelerate our progress in delivering value to surgeons and patients worldwide.\u201d<\/em><\/p>\n

The Board of Directors expresses its sincere gratitude to Torbj\u00f6rn Sk\u00f6ld for his contributions to the company over the past two years.<\/p>\n<\/div>\n

\n

This information is information that Stille is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-05-09 08:00 CEST.<\/em><\/p>\n<\/div>\n

\n

Contact Details<\/strong>
J\u00f3n Sigurdsson<\/strong>
Chairman of the Board
+35 (0) 466 41 02 | jon@emblamedical.com<\/a>\u00a0<\/p>\n<\/div>\n

\n

About Us<\/strong>
Stille AB (publ) develops, manufactures and markets medical devices<\/strong> for surgeons across the world. Stille was founded in 1841 and is one of the world\u2019s oldest medical device companies. Stille\u2019s main business areas are surgical instruments and c-arm tables. Stille\u2019s surgical instruments are mostly used during different kinds of open surgery. During minimal invasive procedures. the c-arm tables imagiQ2 and Medstone are key products. The company has a strong brand and products of a renowned high-quality. The share is listed on First North Growth Market under the acronym \u201cSTIL\u201d with Eminova AB as Certified Adviser, Eminova Fondkommission AB, + 46 8 684 211 10, adviser@eminova.se. For more information, visit www.stille.se<\/a>.<\/p>\n<\/div>\n

\n

Attachments<\/strong>
Stille AB appoints Ulrik Berthelsen as Chief Executive Officer<\/a><\/p>\n<\/div>\n